Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1
- 25 October 2001
- journal article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 20 (48), 6983-6993
- https://doi.org/10.1038/sj.onc.1204892
Abstract
Malignant transformation occurs in cells that overexpress c-Myc or that inappropriately activate E2F-1. Transformation occurs after the selection of cells that have acquired resistance to apoptosis that is triggered by these oncogenes, and a key mediator of this cell death process is the p53 tumor suppressor. In IL-3-dependent immortal 32D.3 myeloid cells the ARF/p53 apoptotic pathway is inactivated, as these cells fail to express ARF. Nonetheless, both c-Myc and E2F-1 overexpression accelerated apoptosis when these cells were deprived of IL-3. Here we report that c-Myc or E2F-1 overexpression suppresses Bcl-2 protein and RNA levels, and that restoration of Bcl-2 protein effectively blocks the accelerated apoptosis that occurs when c-Myc- or E2F-1-overexpressing cells are deprived of IL-3. Blocking p53 activity with mutant p53 did not abrogate E2F-1-induced suppression of Bcl-2. Analysis of immortal myeloid cells engineered to overexpress c-Myc and E2F-1 DNA binding mutants revealed that DNA binding activity of these oncoproteins is required to suppress Bcl-2 expression. These results suggest that the targeting of Bcl-2 family members is an important mechanism of oncogene-induced apoptosis, and that this occurs independent of the ARF/p53 pathway.Keywords
This publication has 60 references indexed in Scilit:
- Apoptosis Triggered by Myc-Induced Suppression of Bcl-XL or Bcl-2 Is Bypassed during LymphomagenesisMolecular and Cellular Biology, 2001
- E2F-1 induces the stabilization of p53 but blocks p53-mediated transactivationOncogene, 2001
- The Max Network Gone MadMolecular and Cellular Biology, 2001
- Induction of ornithine decarboxylase by IL-3 is mediated by sequential c-Myc-independent and c-Myc-dependent pathwaysOncogene, 1997
- bcl-x exhibits regulated expression during B cell development and activation and modulates lymphocyte survival in transgenic mice.The Journal of Experimental Medicine, 1996
- c-Myc and apoptosisBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1995
- Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1.Genes & Development, 1994
- Direct role for Myc in transcription initiation mediated by interactions with TFII-INature, 1993
- Induction of apoptosis in fibroblasts by c-myc proteinCell, 1992
- myc oncogenes: activation and amplificationBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1987